Standard BioTools (STU:FLB) Accounts Payable & Accrued Expense : €26.9 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Standard BioTools Accounts Payable & Accrued Expense?

Standard BioTools's quarterly accounts payable & accrued expense declined from Sep. 2023 (€18.8 Mil) to Dec. 2023 (€18.5 Mil) but then increased from Dec. 2023 (€18.5 Mil) to Mar. 2024 (€26.9 Mil).

Standard BioTools's annual accounts payable & accrued expense declined from Dec. 2021 (€21.4 Mil) to Dec. 2022 (€18.2 Mil) but then increased from Dec. 2022 (€18.2 Mil) to Dec. 2023 (€18.5 Mil).

Standard BioTools Accounts Payable & Accrued Expense Historical Data

The historical data trend for Standard BioTools's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Standard BioTools Accounts Payable & Accrued Expense Chart

Standard BioTools Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

12.62

17.35

21.40

18.20

18.53

Standard BioTools Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															18.32	17.85	18.80	18.53	26.87

Standard BioTools Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Standard BioTools (STU:FLB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Standard BioTools Inc (STU:FLB) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

LAB:USA FLB:Germany

Address

2 Tower Place, Suite 2000, South San Francisco, CA, USA, 94080

Website

https://www.standardbio.com

Standard BioTools Inc manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. The company's segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Standard BioTools (STU:FLB) Headlines

No Headlines